KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine in vitro .
Lucia NovelliCristiana BarbatiCristina CapuanoSerena RecalchiFulvia CeccarelliMarta VomeroCristiano AlessandriStefania MorroneFabrizio ContiPublished in: Lupus (2023)
With this study we revealed a reduced expression and an impaired function of KLRG1 on NK cells in SLE patients. These results suggest a possible role of KLRG1 in the pathogenesis of SLE and as a novel biomarker of this disease.